Recommendations
| ShowHide Related Items >><< - $174.77 /
+0.885 (+0.51%) - 01/31/23
- Target says Omaha West store closed until further notice following incident
- 01/09/23
- Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers
- 12/22/22
- Target recalls roughly 204,000 children's weighted blankets after two deaths
- 11/25/22
- Target announces Cyber Monday sales event from Nov. 27-28
- 02/07/23
- Bed Bath & Beyond: Default under credit agreement waived
- 02/07/23
- Bed Bath & Beyond has initiated incremental store closures
- 02/07/23
- Bed Bath & Beyond completes public equity offering
- 02/07/23
- Bed Bath & Beyond completes public equity offering, provides strategic update
- $174.77 /
+0.885 (+0.51%) - 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- Target initiated with an Equal Weight at Barclays
- 01/23/23 Oppenheimer
- Target initiated with an Outperform at Oppenheimer
- 01/04/23 Wells Fargo
- Wells Fargo downgrades Target to Equal Weight, lowers price target to $142
- 02/07/23 Odeon Capital
- Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
- 02/07/23 Wedbush
- Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy
- 01/11/23 Wedbush
- Bed Bath & Beyond price target lowered to $1 from $5 at Wedbush
- 01/11/23 Baird
- Bed Bath & Beyond price target lowered to $1.00 from $2.00 at Baird
- $174.77 /
+0.885 (+0.51%) - 11/16/22
- Target on track to deliver total sales of well over $100B this year, says COO
- 11/16/22
- Target reports Q3 adjusted EPS $1.54, consensus $2.13
- 11/15/22
- Notable companies reporting before tomorrow's open
- 11/15/22
- Notable companies reporting before tomorrow's open
- 01/10/23
- Bed Bath & Beyond reports Q3 adjusted EPS ($3.65), consensus ($2.11)
- 01/05/23
- Bed Bath & Beyond sees Q3 net sales of about $1.26B, consensus $1.4B
- 09/29/22
- Bed Bath & Beyond reports Q2 adjusted EPS ($3.22), consensus ($1.85)
- 09/28/22
- Notable companies reporting before tomorrow's open
- $174.77 /
+0.885 (+0.51%) - 11/14/22
- Walmart taking 'aggressive' stance with suppliers, WSJ reports
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 09/03/22
- Target's problems won't last forever, time to buy stock, Barron's says
- 02/07/23
- Hudson Bay anchor investor of Bed Bath share sale, Bloomberg reports
- 02/02/23
- Bed Bath & Beyond misses interest payments, weighs Chapter 11, WSJ reports
- 01/31/23
- Bed Bath & Beyond prepares to seek bankruptcy protection, Reuters reports
- 01/29/23
- Bed Bath & Beyond to close 87 more stores, Harmon chain, WSJ reports
- $174.77 /
+0.885 (+0.51%) - 01/28/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 01/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 02/07/23
- Fly Intel: Pre-market Movers
- 02/06/23
- Fly Intel: After-Hours Movers
- $174.77 /
+0.885 (+0.51%) - 01/19/23
- Target put volume heavy and directionally bearish
- 01/06/23
- Early notable gainers among liquid option names on January 6th
- 01/06/23
- Unusually active option classes on open January 6th
- 11/28/22
- Early notable gainers among liquid option names on November 28th
- 02/07/23
- Notable open interest changes for February 7th
- 02/07/23
- Bed Bath & Beyond call buyer realizes 918% same-day gains
- 02/01/23
- Notable open interest changes for February 1st
- 01/27/23
- Notable open interest changes for January 27th
|
Earnings
| ShowHide Related Items >><< EPC Edgewell Personal Care - 12/16/22
- Edgewell Personal Care names Robert Schmidt as Chief Accounting Officer
- 09/15/22
- Edgewell Personal Care streamlines leadership and organizational structure
EPC Edgewell Personal Care - 11/16/22 Canaccord
- Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom'
- 11/16/22 Canaccord
- Edgewell Personal Care initiated with a Buy at Canaccord
- 11/14/22 Barclays
- Edgewell Personal Care price target raised to $35 from $31 at Barclays
- 10/25/22 Goldman Sachs
- Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs
EPC Edgewell Personal Care - 11/10/22
- Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.56
- 11/10/22
- Edgewell Personal Care reports Q4 adjusted EPS 79c, consensus 76c
|
Earnings
| ShowHide Related Items >><< - $100.65 /
-0.835 (-0.82%) - 12/01/22
- Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets
- 11/07/22
- Ingredion completes one-third of its $160M in capital investments
- 09/26/22
- Ingredion announces 6M share repurchase plan
- 09/26/22
- Ingredion increases quarterly dividend 9% to 71c per share
- $100.65 /
-0.835 (-0.82%) - 01/23/23 Barclays
- Ingredion downgraded to Equal Weight from Overweight at Barclays
- 01/17/23 Stephens
- Ingredion upgraded to Overweight from Equal Weight at Stephens
- 11/07/22 Credit Suisse
- Ingredion price target raised to $100 from $94 at Credit Suisse
- 09/30/22 UBS
- Ingredion initiated with a Neutral at UBS
- $100.65 /
-0.835 (-0.82%) - 06:06 Today
- Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45
- 11/03/22
- Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45
- 11/03/22
- Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62
- 08/09/22
- Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14
- $100.65 /
-0.835 (-0.82%) - 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/26/22
- Fly Intel: After-Hours Movers
|
Upgrade
| ShowHide Related Items >><< - 02/07/23
- Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance
- 02/07/23
- Royal Caribbean sees FY23 CapEx $4.1B
- 02/07/23
- Royal Caribbean 'very encouraged about the demand environment for 2023'
- 01/12/23
- Royal Caribbean amends, extends revolving credit facilities
- 05:34 Today Barclays
- Royal Caribbean price target raised to $88 from $74 at Barclays
- 04:44 Today Deutsche Bank
- Royal Caribbean price target raised to $65 from $62 at Deutsche Bank
- 01/31/23 Citi
- Royal Caribbean offers most value in cruise sector, says Citi
- 01/20/23 Deutsche Bank
- Royal Caribbean price target raised to $62 from $48 at Deutsche Bank
- 02/07/23
- Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25
- 02/07/23
- Royal Caribbean sees Q1 adjusted EPS (85c)-(65c), consensus (80c)
- 02/07/23
- Royal Caribbean reports Q4 adjusted EPS ($1.12), consensus ($1.34)
- 11/03/22
- Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c)
- 08/17/22
- Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports
- 08/13/22
- Royal Caribbean among companies at risk of liquidity squeeze, Barron's says
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 01/10/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/10/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/07/23
- Early notable gainers among liquid option names on February 7th
- 02/07/23
- Unusually active option classes on open February 7th
- 01/19/23
- Royal Caribbean put volume heavy and directionally bearish
- 12/21/22
- Early notable gainers among liquid option names on December 21st
|
Earnings
| ShowHide Related Items >><< - $100.65 /
-0.835 (-0.82%) - 12/01/22
- Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets
- 11/07/22
- Ingredion completes one-third of its $160M in capital investments
- 09/26/22
- Ingredion announces 6M share repurchase plan
- 09/26/22
- Ingredion increases quarterly dividend 9% to 71c per share
- $100.65 /
-0.835 (-0.82%) - 01/23/23 Barclays
- Ingredion downgraded to Equal Weight from Overweight at Barclays
- 01/17/23 Stephens
- Ingredion upgraded to Overweight from Equal Weight at Stephens
- 11/07/22 Credit Suisse
- Ingredion price target raised to $100 from $94 at Credit Suisse
- 09/30/22 UBS
- Ingredion initiated with a Neutral at UBS
- $100.65 /
-0.835 (-0.82%) - 11/03/22
- Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45
- 11/03/22
- Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62
- 08/09/22
- Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14
- 08/09/22
- Ingredion reports Q2 adjusted EPS $2.12, consensus $1.94
- $100.65 /
-0.835 (-0.82%) - 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/26/22
- Fly Intel: After-Hours Movers
|
Hot Stocks
| ShowHide Related Items >><< - 01/04/23
- Maxar Technologies announces new contract awards from NGA worth up to $35.8M
- 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/27/22 Morgan Stanley
- Morgan Stanley says space-related M&A highlight attractiveness of end market
- 12/19/22 Northland
- Maxar deal sheds light on growing value of Planet Labs data, says Northland
- 12/19/22 TD Securities
- Maxar Technologies downgraded to Tender from Buy at TD Securities
- 12/19/22 RBC Capital
- Maxar Technologies downgraded to Sector Perform from Outperform at RBC Capital
- 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 12/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- Sell these stocks now, proven algorithm says
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/20/22
- Maxar Technologies put volume heavy and directionally bearish
|
Earnings
| ShowHide Related Items >><< - 06:03 Today
- CVS Health to acquire Oak Street Health for $39 per share
- 01/26/23
- Medavail to sell certain SpotRx pharmacy assets to CVS Health
- 01/23/23
- CVS Health names Bricker CPO, Joyner rejoins as pharmacy services president
- 01/17/23
- Oak Street Health down 7% in afternoon trading
- 02/07/23 Stifel
- Oak Street Health price target raised to $39 from $35 at Stifel
- 02/07/23 Piper Sandler
- Oak Street 'particularly attractive' in current environment, says Piper Sandler
- 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/27/23 Lake Street
- Medavail price target lowered to $1 from $4 at Lake Street
- 06:04 Today
- CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 01/10/23
- CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- 02/06/23
- CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says
- 02/06/23
- CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says
- 01/27/23
- Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says
- 01/19/23
- Rite Aid plans to provide abortion pill in some stores, Bloomberg reports
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 02/07/23
- Fly Intel: Pre-market Movers
- 01/27/23
- What You Missed On Wall Street This Morning
- 11/28/22
- CVS Health put volume heavy and directionally bearish
- 11/02/22
- Unusually active option classes on open November 2nd
- 10/19/22
- Unusually active option classes on open October 19th
- 09/13/22
- CVS Health call volume above normal and directionally bullish
|
Earnings
| ShowHide Related Items >><< - 02/07/23
- Bunge increases monitoring of soybeans from indirect supply chain in Brazil
- 11/22/22
- Bunge to acquire 49% stake in BZ Group, terms undisclosed
- 10/13/22
- Bunge, Olleco announce 50/50 edible oils joint venture
- 10/10/22
- Bunge announces over 100 new trainee, internship positions in North America
- 12/14/22 UBS
- UBS starts Bunge at Buy on near-term earnings power
- 12/13/22 UBS
- Bunge initiated with a Buy at UBS
- 10/24/22 BofA
- Green Plains price target lowered to $35 from $43 at BofA
- 10/24/22 BofA
- Bunge price target lowered to $130 from $138 at BofA
- 06:01 Today
- Bunge reports Q4 adjusted EPS $3.24, consensus $3.22
- 10/26/22
- Bunge raises FY22 adjusted EPS view to at least $13.50 from at least $12.00
- 10/26/22
- Bunge reports Q3 adjusted EPS $3.45, consensus $2.43
- 11/30/22
- EPA to propose boost in biofuel quotas, Reuters reports
- 11/30/22
- President Biden plans to boost biofuel quotas for next 3 years, Bloomberg says
- 12/14/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Recommendations
|
Piper Sandler analyst Rob… ShowHide Related Items >><< - 01/26/23
- Tenable Holdings announces Tenable Ventures, a corporate investment program
- 10/31/22
- Tenable announces Michelle VonderHaar as chief legal officer, general counsel
- 10/11/22
- Tenable Holdings announces creation of Tenable Research Alliance Program
- 10/04/22
- Tenable Holdings announces release of Tenable One
- 05:36 Today Barclays
- Tenable Holdings price target raised to $50 from $42 at Barclays
- 01/24/23 JPMorgan
- Tenable Holdings initiated with a Neutral at JPMorgan
- 01/12/23 Morgan Stanley
- Tenable Holdings downgraded at Morgan Stanley amid near-term security caution
- 01/12/23 Morgan Stanley
- Tenable Holdings downgraded to Equal Weight from Overweight at Morgan Stanley
- 02/07/23
- Tenable Holdings sees FY23 EPS 52c-56c, consensus 50c
- 02/07/23
- Tenable Holdings sees Q1 EPS 2c-3c, consensus 9c
- 02/07/23
- Tenable Holdings reports Q4 EPS 12c, consensus 7c
- 10/25/22
- Tenable Holdings sees FY22 EPS 32c-33c, consensus 19c
- 02/07/23
- Fly Intel: After-Hours Movers
- 01/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/25/22
- Fly Intel: After-Hours Movers
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Periodicals
| ShowHide Related Items >><< - 02/07/23
- Toast announces the Order with Google integration, unlocking new order channel
- 02/06/23
- Google releases conversational AI service Bard for testing
- 02/06/23
- Texas Governor Abbott announces statewide plan banning use of TikTok
- 02/03/23
- Google, Anthropic partner to co-develop AI computing systems
- 02/06/23
- Google releases conversational AI service Bard for testing
- 02/06/23
- Texas Governor Abbott announces statewide plan banning use of TikTok
- 02/03/23
- Google, Anthropic partner to co-develop AI computing systems
- 02/02/23
- Alphabet says started bringing revenue sharing to YouTube Shorts
- $267.58 /
+10.605 (+4.13%) - 02/07/23
- Microsoft unveils new AI-powered Bing search engine and Edge browser
- 02/07/23
- KnowBe4 joins MISA, integrates with Microsoft security products
- 02/07/23
- Enthusiast Gaming renews partnership with Xbox
- 02/03/23
- Activision Blizzard to pay $35M in settlement with SEC over whistleblower rule
- 02/07/23 Wedbush
- Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
- 02/03/23 JPMorgan
- Alphabet price target raised to $118 from $115 at JPMorgan
- 02/03/23 Credit Suisse
- Alphabet price target lowered to $136 from $145 at Credit Suisse
- 02/03/23 Morgan Stanley
- Alphabet price target raised to $135 from $125 at Morgan Stanley
- 02/07/23 Wedbush
- Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
- 02/03/23 Truist
- Alphabet price target lowered to $120 from $130 at Truist
- 02/03/23 DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 02/03/23 Roth MKM
- Alphabet price target raised to $126 from $120 at Roth MKM
- $267.58 /
+10.605 (+4.13%) - 06:03 Today Piper Sandler
- Microsoft price target raised to $290 from $247 at Piper Sandler
- 05:21 Today Jefferies
- Microsoft price target raised to $310 from $275 at Jefferies
- 02/07/23 Stifel
- Stifel says average public ad tech multiple values Criteo near $45 per share
- 02/07/23 Wedbush
- Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- $267.58 /
+10.605 (+4.13%) - 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 02/07/23
- Microsoft announces Bing search engine powered by OpenAI, Bloomberg says
- 02/06/23
- FTC yields to 'defeat' in antitrust battle with Facebook, Gizmodo reports
- 02/06/23
- Microsoft surprise event expected to focus on Bing ChatGPT, The Verge says
- 02/03/23
- Google invests $300M in AI startup Anthropic, FT reports
- 02/07/23
- Microsoft announces Bing search engine powered by OpenAI, Bloomberg says
- 02/06/23
- FTC yields to 'defeat' in antitrust battle with Facebook, Gizmodo reports
- 02/06/23
- Microsoft surprise event expected to focus on Bing ChatGPT, The Verge says
- 02/03/23
- Google invests $300M in AI startup Anthropic, FT reports
- $267.58 /
+10.605 (+4.13%) - 05:35 Today
- Activision CEO appeals to U.K. to approve Microsoft deal, FT reports
- 02/07/23
- Microsoft to release ChatGPT tech to help companies make bots, CNBC says
- 02/07/23
- Microsoft announces Bing search engine powered by OpenAI, Bloomberg says
- 02/06/23
- Microsoft surprise event expected to focus on Bing ChatGPT, The Verge says
- 02/06/23
- What Wall Street is saying about Pinterest ahead of earnings
- 02/03/23
- What You Missed On Wall Street On Friday
- 02/03/23
- What You Missed On Wall Street This Morning
- 02/03/23
- Fly Intel: Pre-market Movers
- 02/06/23
- What Wall Street is saying about Pinterest ahead of earnings
- 02/03/23
- What You Missed On Wall Street On Friday
- 02/03/23
- What You Missed On Wall Street This Morning
- 02/03/23
- Fly Intel: Pre-market Movers
- $267.58 /
+10.605 (+4.13%) - 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed This Week in Video Games
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/02/23
- Alphabet options imply 5.9% move in share price post-earnings
- 01/20/23
- Unusually active option classes on open January 20th
- 12/14/22
- Alphabet put buyer realizes 126% same-day gains
- 11/02/22
- Alphabet put buyer realizes 98% same-day gains
- 02/07/23
- Alphabet Class A call volume above normal and directionally bullish
- 02/03/23
- Notable open interest changes for February 3rd
- 02/02/23
- Alphabet Class A options imply 5.4% move in share price post-earnings
- 02/02/23
- Early notable gainers among liquid option names on February 2nd
- $267.58 /
+10.605 (+4.13%) - 01/30/23
- Largest borrow rate increases among liquid names
- 01/27/23
- Largest borrow rate increases among liquid names
- 01/25/23
- Notable open interest changes for January 25th
- 01/24/23
- Microsoft options imply 4.4% move in share price post-earnings
|